Pacira BioSciences (PCRX) Payables: 2009-2025
Historic Payables for Pacira BioSciences (PCRX) over the last 15 years, with Sep 2025 value amounting to $17.7 million.
- Pacira BioSciences' Payables fell 8.67% to $17.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $90.1 million, marking a year-over-year increase of 43.55%. This contributed to the annual value of $19.1 million for FY2024, which is 21.88% up from last year.
- According to the latest figures from Q3 2025, Pacira BioSciences' Payables is $17.7 million, which was down 41.29% from $30.1 million recorded in Q2 2025.
- Pacira BioSciences' 5-year Payables high stood at $30.1 million for Q2 2025, and its period low was $7.9 million during Q3 2021.
- Over the past 3 years, Pacira BioSciences' median Payables value was $18.7 million (recorded in 2024), while the average stood at $19.2 million.
- As far as peak fluctuations go, Pacira BioSciences' Payables crashed by 47.96% in 2024, and later spiked by 157.98% in 2025.
- Pacira BioSciences' Payables (Quarterly) stood at $10.5 million in 2021, then spiked by 44.36% to $15.2 million in 2022, then rose by 3.14% to $15.7 million in 2023, then rose by 21.88% to $19.1 million in 2024, then fell by 8.67% to $17.7 million in 2025.
- Its last three reported values are $17.7 million in Q3 2025, $30.1 million for Q2 2025, and $23.2 million during Q1 2025.